UPDATE: Auriga Upgrades Lifepoint Holdings (LPNT) to Buy; Use Recent Pullback As Opportunity
Tweet
Share
E-mailGet Alerts LPNT Hot Sheet
Price: $64.99 --0%
Rating Summary:
4 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 8
Rating Summary:
4 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 8
Join SI Premium – FREE
(Updated - May 23, 2012 12:45 PM EDT)
Auriga upgraded Lifepoint Holdings (NASDAQ: LPNT) from Hold to Buy with a price target of $41.00.
Analyst, Glen Losev, said, "The pullback in the stock, improved traction from the company's focus on outpatient services (which drove growth in surgical cases in 1Q12), increasing M&A activity, as well as the size of acquisitions through the LPNT - Duke joint venture has improved the risk/reward ratio in our opinion. We believe if 1Q growth trends, increasing surgical volume (likely), and increasing acquisition pace and size (likely) continue, LPNT will be able to deliver earnings above our and current consensus estimates."
"Good things were apparent in 1Q12...LPNT reported in line (with our) and above consensus expectations 1Q12 results. The quarter was highlighted by improving overall volume trend (when adjusting for the weak flu season), outpatient surgical growth, and rising case mix..."
For an analyst ratings summary and ratings history on Lifepoint Holdings click here. For more ratings news on Lifepoint Holdings click here.
Shares of Lifepoint Holdings closed at $35.31 yesterday.
Auriga upgraded Lifepoint Holdings (NASDAQ: LPNT) from Hold to Buy with a price target of $41.00.
Analyst, Glen Losev, said, "The pullback in the stock, improved traction from the company's focus on outpatient services (which drove growth in surgical cases in 1Q12), increasing M&A activity, as well as the size of acquisitions through the LPNT - Duke joint venture has improved the risk/reward ratio in our opinion. We believe if 1Q growth trends, increasing surgical volume (likely), and increasing acquisition pace and size (likely) continue, LPNT will be able to deliver earnings above our and current consensus estimates."
"Good things were apparent in 1Q12...LPNT reported in line (with our) and above consensus expectations 1Q12 results. The quarter was highlighted by improving overall volume trend (when adjusting for the weak flu season), outpatient surgical growth, and rising case mix..."
For an analyst ratings summary and ratings history on Lifepoint Holdings click here. For more ratings news on Lifepoint Holdings click here.
Shares of Lifepoint Holdings closed at $35.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
- W.R. Berkley (WRB) PT Lowered to $93 at Truist Securities
- Travelzoo (TZOO) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
UpgradesRelated Entities
Auriga, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
